Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$783M |
| 2 |
Danaher
DHR
|
+$423M |
| 3 |
Prologis
PLD
|
+$411M |
| 4 |
Apple
AAPL
|
+$388M |
| 5 |
Amazon
AMZN
|
+$325M |
Top Sells
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$505M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Ichor Holdings
ICHR
$579M
| $14.4M | ﹤0.01% |
536,603
+19,879
| +4% | +$533K |
|
2002
Collegium Pharmaceutical
COLL
$1.18B
| $14.4M | ﹤0.01% |
618,917
+13,225
| +2% | +$307K |
|
2003
Icon
ICLR
$13.6B
| $14.3M | ﹤0.01% |
73,872
+259
| +0.4% | +$50.3K |
|
2004
TPG
TPG
$9.05B
| $14.3M | ﹤0.01% |
514,778
+29,885
| +6% | +$832K |
|
|
PAYA
2005
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $14.3M | ﹤0.01% |
1,819,580
+45,403
| +3% | +$357K |
|
2006
Myers Industries
MYE
$587M
| $14.3M | ﹤0.01% |
644,171
+14,818
| +2% | +$329K |
|
2007
Univest Financial
UVSP
$886M
| $14.3M | ﹤0.01% |
547,183
+10,070
| +2% | +$263K |
|
2008
National Healthcare
NHC
$1.78B
| $14.3M | ﹤0.01% |
239,997
+8,640
| +4% | +$514K |
|
2009
Anywhere Real Estate
HOUS
$800M
| $14.3M | ﹤0.01% |
2,234,187
-37,137
| -2% | -$237K |
|
|
RWT
2010
Redwood Trust
RWT
$804M
| $14.3M | ﹤0.01% |
2,110,697
-26,791
| -1% | -$181K |
|
2011
Caleres
CAL
$503M
| $14.3M | ﹤0.01% |
640,170
+12,625
| +2% | +$281K |
|
|
OPI
2012
Office Properties Income Trust
OPI
$40.8M
| $14.3M | ﹤0.01% |
1,067,970
+24,598
| +2% | +$328K |
|
2013
Metallus
MTUS
$697M
| $14.2M | ﹤0.01% |
782,109
+10,492
| +1% | +$191K |
|
2014
Hanmi Financial
HAFC
$748M
| $14.2M | ﹤0.01% |
573,339
+17,235
| +3% | +$427K |
|
|
UHT
2015
Universal Health Realty Income Trust
UHT
$575M
| $14.2M | ﹤0.01% |
297,230
-548
| -0.2% | -$26.2K |
|
|
INBX
2016
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $14.2M | ﹤0.01% |
575,697
+78,890
| +16% | +$1.94M |
|
2017
Heartland Express
HTLD
$656M
| $14.1M | ﹤0.01% |
922,122
+21,401
| +2% | +$328K |
|
2018
Ambac
AMBC
$413M
| $14.1M | ﹤0.01% |
810,842
+12,564
| +2% | +$219K |
|
2019
Cogent Biosciences
COGT
$1.77B
| $14.1M | ﹤0.01% |
1,222,330
+47,570
| +4% | +$550K |
|
|
MORF
2020
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $14.1M | ﹤0.01% |
527,235
+24,285
| +5% | +$650K |
|
2021
Ubiquiti
UI
$36.6B
| $14.1M | ﹤0.01% |
51,433
-4,776
| -8% | -$1.31M |
|
2022
Hims & Hers Health
HIMS
$12.5B
| $14.1M | ﹤0.01% |
2,193,273
+76,928
| +4% | +$493K |
|
|
CUTR
2023
DELISTED
Cutera, Inc.
CUTR
| $14M | ﹤0.01% |
317,000
+11,963
| +4% | +$529K |
|
|
PRVB
2024
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $14M | ﹤0.01% |
1,322,189
+125,392
| +10% | +$1.33M |
|
|
ZUO
2025
DELISTED
Zuora, Inc.
ZUO
| $14M | ﹤0.01% |
2,195,227
+83,964
| +4% | +$534K |
|